6271 - 6280 of 6514 Results
Title
Year
-
OPENTitle: Single-cell spatial transcriptomic and translatomic profiling of dopaminergic neurons in health, aging, and diseaseJournal Name: Cell ReportsPublisher: Elsevier BVVol: 43Issue #: 3Start Page: 113784End Page: 113784Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-by, cc-by, cc-byDOI - Digital Object Identifier: 10.1016/j.celrep.2024.113784Best OA location URL: http://www.cell.com/article/S2211124724001128/pdfCitation Count: 26
-
OPENTitle: Evaluation of ATN PD Framework and Biofluid Markers to Predict Cognitive Decline in Early Parkinson DiseaseJournal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 102Issue #: 4Start Page: e208033End Page: e208033Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1212/wnl.0000000000208033Best OA location URL: https://pmc.ncbi.nlm.nih.gov/articles/PMC11383879/pdf/WNL-2023-001997.pdfCitation Count: 20
-
OPENTitle: Perspective Strategies for Interventions in Parkinsonism: Remedying the Neglected Role of TPPPJournal Name: CellsPublisher: MDPI AGVol: 13Issue #: 4Start Page: 338End Page: 338Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3390/cells13040338Best OA location URL: https://www.mdpi.com/2073-4409/13/4/338/pdf?version=1707879942Citation Count: 1
-
OPENTitle: The Association of Antidepressant Use and Impulse Control Disorder in Parkinson's DiseaseJournal Name: The American Journal of Geriatric PsychiatryPublisher: Elsevier BVVol: 32Issue #: 6Start Page: 710End Page: 720Publication Date:Open Access(OA) Status: OPENLicense: other-oaDOI - Digital Object Identifier: 10.1016/j.jagp.2023.12.024Best OA location URL: https://pmc.ncbi.nlm.nih.gov/articles/PMC11096064/pdf/nihms-1958243.pdfCitation Count: 9
-
OPENTitle: Association of liver fibrosis with cognitive decline in Parkinson’s diseaseJournal Name: Journal of Clinical NeurosciencePublisher: Elsevier BVVol: 119Issue #:Start Page: 10End Page: 16Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.jocn.2023.11.019Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/11198872Citation Count: 7
-
OPENTitle: Clinical prediction of GBA carrier status in Parkinson’s diseaseJournal Name: Clinical Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 10Issue #:Start Page: 100251End Page: 100251Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1016/j.prdoa.2024.100251Best OA location URL: https://doi.org/10.1016/j.prdoa.2024.100251Citation Count: 1
-
OPENTitle: Longitudinal analysis of impulse control disorders in Parkinson diseaseJournal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 91Issue #: 3Start Page: e189End Page: e201Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1212/wnl.0000000000005816Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/6059034Citation Count: 242
-
OPENTitle: Unique white matter structural connectivity in early-stage drug-naive Parkinson diseaseJournal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 94Issue #: 8Start Page: e774End Page: e784Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1212/wnl.0000000000008867Best OA location URL: https://n.neurology.org/content/neurology/94/8/e774.full.pdfCitation Count: 45
-
OPENTitle: Candidate inflammatory biomarkers display unique relationships with alpha-synuclein and correlate with measures of disease severity in subjects with Parkinson’s diseaseJournal Name: Journal of NeuroinflammationPublisher: Springer Science and Business Media LLCVol: 14Issue #: 1Start Page: 164End Page: 164Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s12974-017-0935-1Best OA location URL: https://jneuroinflammation.biomedcentral.com/track/pdf/10.1186/s12974-017-0935-1Citation Count: 102
- Oligomeric and phosphorylated alpha-synuclein as potential CSF biomarkers for Parkinson’s disease2016OPENTitle: Oligomeric and phosphorylated alpha-synuclein as potential CSF biomarkers for Parkinson’s diseaseJournal Name: Molecular NeurodegenerationPublisher: Springer Science and Business Media LLCVol: 11Issue #: 1Start Page: 7End Page: 7Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s13024-016-0072-9Best OA location URL: https://molecularneurodegeneration.biomedcentral.com/track/pdf/10.1186/s13024-016-0072-9Citation Count: 285